Skip to content
The Great News – Lifestyle
Home
Sample Page
Author:
Saol Therapeutics
Saol Therapeutics Resubmits the New Drug Application for SL1009 (DCA) for the Treatment of Pyruvate Dehydrogenase Complex Deficiency (PDCD), an Ultra-Rare Disease
July 7, 2026